Cite
Estimation of linezolid exposure in patients with hepatic impairment using machine learning based on a population pharmacokinetic model.
MLA
Liao, Ru, et al. “Estimation of Linezolid Exposure in Patients with Hepatic Impairment Using Machine Learning Based on a Population Pharmacokinetic Model.” European Journal of Clinical Pharmacology, vol. 80, no. 8, Aug. 2024, pp. 1241–51. EBSCOhost, https://doi.org/10.1007/s00228-024-03698-2.
APA
Liao, R., Chen, L., Cheng, X., Li, H., Wang, T., Dong, Y., & Dong, H. (2024). Estimation of linezolid exposure in patients with hepatic impairment using machine learning based on a population pharmacokinetic model. European Journal of Clinical Pharmacology, 80(8), 1241–1251. https://doi.org/10.1007/s00228-024-03698-2
Chicago
Liao, Ru, Lihong Chen, Xiaoliang Cheng, Houli Li, Taotao Wang, Yalin Dong, and Haiyan Dong. 2024. “Estimation of Linezolid Exposure in Patients with Hepatic Impairment Using Machine Learning Based on a Population Pharmacokinetic Model.” European Journal of Clinical Pharmacology 80 (8): 1241–51. doi:10.1007/s00228-024-03698-2.